Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
229 studies found for:    nash
Show Display Options
Rank Status Study
21 Completed Omega 3 Supplementation in Fatty Liver
Condition: Fatty Liver
Intervention: Dietary Supplement: Omega 3
22 Completed
Has Results
Treating Nonalcoholic Steatohepatitis (NASH) With Metformin
Condition: Hepatitis
Intervention: Drug: Metformin
23 Terminated Effects of Rosiglitazone and Alpha-lipoic Acid on the Patients With Pathologically Proved NASH
Condition: NASH (Non-alcoholic Steato-hepatitis)
Interventions: Drug: Rosiglitazone;   Drug: alpha-lipoic acid;   Drug: Rosiglitazone/alpha-lipoic acid
24 Completed Role of Exenatide in NASH-a Pilot Study
Conditions: Nonalcoholic Fatty Liver Disease;   (NAFLD)
Intervention: Drug: Exenatide
25 Recruiting Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: placebo;   Drug: pioglitazone;   Dietary Supplement: Vitamin E;   Drug: Vitamin E placebo
26 Completed Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Pioglitazone;   Drug: Placebo
27 Unknown  Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
Conditions: Nonalcoholic Steatohepatitis;   Nonalcoholic Fatty Liver Disease
Interventions: Drug: avandia;   Drug: metformin;   Drug: losartan
28 Terminated Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions Pilot Trial
Condition: Articular Cartilage Injury
Interventions: Device: Kensey Nash Corp. Cartilage Repair Device;   Procedure: Microfracture
29 Completed Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
Conditions: Nonalcoholic Steatohepatitis;   Fatty Liver Disease
Intervention: Dietary Supplement: Bovine colostrum powder
30 Completed Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Fatty Liver Disease
Intervention: Drug: Exenatide
31 Recruiting Efficacy and Safety Study of Cenicriviroc for the Treatment of NASH in Adult Subjects With Liver Fibrosis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: Cenicriviroc;   Drug: Placebo
32 Enrolling by invitation Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis
Condition: •Non-alcoholic Steatohepatitis (NASH)
Interventions: Drug: Ezetimibe;   Behavioral: Lifestyle
33 Completed Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)
Condition: Fatty Liver Disease, Nonalcoholic
Intervention: Drug: metreleptin
34 Not yet recruiting Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin
Condition: Non-alcoholic Steatohepatitis
Intervention: Radiation: Tc 99m MEB
35 Recruiting Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
36 Active, not recruiting Impact of Muscle Insulin Resistance on the Pathogenesis of Non Alcoholic Steatohepatitis
Condition: Non Alcoholic Fatty Liver Diseases (NAFLD)
Intervention:
37 Recruiting Gut Microbiota and Modulation of Liver Damage in NAFLD
Conditions: Simple Steatosis (SS);   Non-alcoholic Steatohepatitis (NASH);   Obesity
Intervention: Procedure: liver and white adipose tissue biopsies
38 Active, not recruiting The Effect of Polypill on Patients With Presumed NASH
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: Polypill
39 Completed A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)
Condition: Fatty Liver
Intervention: Drug: IdB 1016 (Siliphos)
40 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years